Global Biosimilar and Biologics Industry set to skyrocket to US$ 1,060.7 Billion by 2034, fueled by a striking 7.6% CAGR | Unveils FMI Report
The Global Biosimilars and Biologics Industry is poised for remarkable expansion. Projections indicate that it will expand from US$ 520.9 billion in 2024 to a staggering US$ 1,060.7 billion by [read full press release…]
